Reviva Pharmaceuticals RVPH Stock
Reviva Pharmaceuticals Price Chart
Reviva Pharmaceuticals RVPH Financial and Trading Overview
| Reviva Pharmaceuticals stock price | 0.89 USD |
| Previous Close | 6.2 USD |
| Open | 6.2 USD |
| Bid | 0 USD x 900 |
| Ask | 0 USD x 3200 |
| Day's Range | 5.93 - 6.37 USD |
| 52 Week Range | 0.53 - 9.25 USD |
| Volume | 174.08K USD |
| Avg. Volume | 188.05K USD |
| Market Cap | 128.35M USD |
| Beta (5Y Monthly) | 0.126138 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -0.78 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 15.4 USD |
RVPH Valuation Measures
| Enterprise Value | 117.24M USD |
| Trailing P/E | N/A |
| Forward P/E | -6.4791665 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 21.978798 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | N/A |
Trading Information
Reviva Pharmaceuticals Stock Price History
| Beta (5Y Monthly) | 0.126138 |
| 52-Week Change | 418.33% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 9.25 USD |
| 52 Week Low | 0.53 USD |
| 50-Day Moving Average | 6.52 USD |
| 200-Day Moving Average | 4.47 USD |
RVPH Share Statistics
| Avg. Volume (3 month) | 188.05K USD |
| Avg. Daily Volume (10-Days) | 192.8K USD |
| Shares Outstanding | 20.63M |
| Float | 15.65M |
| Short Ratio | 6.11 |
| % Held by Insiders | 24.20% |
| % Held by Institutions | 6.37% |
| Shares Short | 1.55M |
| Short % of Float | 10.19% |
| Short % of Shares Outstanding | 7.50% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -77.25% |
| Return on Equity (ttm) | -173.70% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | N/A |
| Net Income Avi to Common (ttm) | -23576828 USD |
| Diluted EPS (ttm) | -1.1 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 11.26M USD |
| Total Cash Per Share (mrq) | 0.55 USD |
| Total Debt (mrq) | 667.5K USD |
| Total Debt/Equity (mrq) | 11.54 USD |
| Current Ratio (mrq) | 1.967 |
| Book Value Per Share (mrq) | 0.283 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -20645200 USD |
| Levered Free Cash Flow (ttm) | -12090754 USD |
Profile of Reviva Pharmaceuticals
| Country | United States |
| State | CA |
| City | Cupertino |
| Address | 19925 Stevens Creek Boulevard |
| ZIP | 95014 |
| Phone | 408 501 8881 |
| Website | https://revivapharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 10 |
Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is brilaroxazine (RP5063), which is in Phase III clinical trials for the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. The company is based in Cupertino, California.
Q&A For Reviva Pharmaceuticals Stock
What is a current RVPH stock price?
Reviva Pharmaceuticals RVPH stock price today per share is 0.89 USD.
How to purchase Reviva Pharmaceuticals stock?
You can buy RVPH shares on the NasdaqCM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Reviva Pharmaceuticals?
The stock symbol or ticker of Reviva Pharmaceuticals is RVPH.
Which industry does the Reviva Pharmaceuticals company belong to?
The Reviva Pharmaceuticals industry is Biotechnology.
How many shares does Reviva Pharmaceuticals have in circulation?
The max supply of Reviva Pharmaceuticals shares is 46.74M.
What is Reviva Pharmaceuticals Price to Earnings Ratio (PE Ratio)?
Reviva Pharmaceuticals PE Ratio is now.
What was Reviva Pharmaceuticals earnings per share over the trailing 12 months (TTM)?
Reviva Pharmaceuticals EPS is -0.78 USD over the trailing 12 months.
Which sector does the Reviva Pharmaceuticals company belong to?
The Reviva Pharmaceuticals sector is Healthcare.
Reviva Pharmaceuticals RVPH included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| NASDAQ Composite IXIC | 19175.87 USD — |
+0.39
|
10.17B USD — | 19091.54 USD — | 19389.39 USD — | — - | 10.17B USD — |
| Nasdaq Health Care IXHC | 955.35 USD — |
+1.49
|
— — | 942.74 USD — | 955.87 USD — | — - | — — |
- {{ link.label }} {{link}}